Literature DB >> 3911724

A national survey of severe group B streptococcal infections in neonates and young infants in Denmark, 1978-83.

H Carstensen, J Henrichsen, O B Jepsen.   

Abstract

During a six-year period, 1978-83, 80 cases of culture proven group B streptococcal (GBS) bacteraemia and meningitis were identified in neonates and young infants up to 12 weeks of age in a national retrospective survey. Two thirds (68%) were early onset disease (EOD) while one third was late onset disease (LOD) occurring later than the seventh day of life. The overall incidence for the period was 0.24 per 1,000 live-born with a trend towards decline through the period. EOD was associated with low birthweight, twin delivery and congenital anomalies as well as with obstetric risk factors like premature or prolonged rupture of membranes and intrapartum fever. The overall case fatality rate was 23%, both in EOD and LOD. Seven (11%) of the surviving infants, six of whom had had meningitis, developed neurological sequelae. Newborns that showed signs of infection with 12 hours of delivery were at a significantly higher risk of running a fulminant course than newborns whose infections developed later (p = 0.02). Nosocomial transmission of GBS seemed limited and most hospital-acquired cases were unconnected.

Entities:  

Mesh:

Year:  1985        PMID: 3911724     DOI: 10.1111/j.1651-2227.1985.tb10060.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  8 in total

1.  Mortality from early onset group B streptococcal infection in the United Kingdom.

Authors:  N Embleton; U Wariyar; E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

2.  Incidence of early onset group B streptococcal septicemia in Sweden 1973 to 1985.

Authors:  I Sjöberg; S Håkansson; A Eriksson; J Schollin; B Stjernstedt; I Tessin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

3.  The Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of neonatal group B streptococcal infections in Canada.

Authors:  H D Davies; J Leblanc; R Bortolussi; A McGeer
Journal:  Paediatr Child Health       Date:  1999-05       Impact factor: 2.253

Review 4.  Typing of Streptococcus agalactiae (Lancefield group B).

Authors:  G Colman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses.

Authors:  Seyhan Boyoglu-Barnum; Geoffrey B Hutchinson; Jeffrey C Boyington; Syed M Moin; Rebecca A Gillespie; Yaroslav Tsybovsky; Tyler Stephens; John R Vaile; Julia Lederhofer; Kizzmekia S Corbett; Brian E Fisher; Hadi M Yassine; Sarah F Andrews; Michelle C Crank; Adrian B McDermott; John R Mascola; Barney S Graham; Masaru Kanekiyo
Journal:  Nat Commun       Date:  2020-02-07       Impact factor: 14.919

6.  Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants.

Authors:  Søren Mose Hansen; Niels Uldbjerg; Mogens Kilian; Uffe B Skov Sørensen
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 7.  Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses.

Authors:  Maya Kohli-Lynch; Neal J Russell; Anna C Seale; Ziyaad Dangor; Cally J Tann; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Paul T Heath; Margaret Ip; Kirsty Le Doare; Shabir A Madhi; Craig E Rubens; Samir K Saha; Stephanie Schrag; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Catherine O'Sullivan; Firdose Nakwa; Hechmi Ben Hamouda; Habib Soua; Kyriaki Giorgakoudi; Shamez Ladhani; Theresa Lamagni; Hilary Rattue; Caroline Trotter; Joy E Lawn
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 9.079

8.  Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape.

Authors:  Nicholas C Wu; Jakub Otwinowski; Andrew J Thompson; Corwin M Nycholat; Armita Nourmohammad; Ian A Wilson
Journal:  Nat Commun       Date:  2020-03-06       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.